Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Statistically significant improvement in FSAD in Alista at-home study

April 3, 2003

Takeda plans two trials of Actos in heart disease

April 3, 2003

Novel NPY antagonists in Banyu development pipeline

April 3, 2003

Regeneron announces positive preliminary phase III results with Axokine

April 3, 2003

GOT trial studies methods for achieving glycemic control in diabetes

April 3, 2003

Amylin submits additional Symlin information to Swiss authorities

April 2, 2003

Novel PDH activators discovered by AstraZeneca scientists

April 2, 2003

Fidarestat prevents retinal oxidative stress and overexpression of VEGF

April 2, 2003

New series with strong activity against PTP1B presented at ACS meeting

April 1, 2003

IL-10 gene therapy prolongs islet graft survival and inhibits diabetes recurrence in mice

April 1, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...